{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T12:24:27Z","timestamp":1785846267341,"version":"3.56.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00228-019-02654-9","type":"journal-article","created":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T12:33:17Z","timestamp":1551443597000},"page":"1005-1015","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Antipsychotic utilization patterns among patients with schizophrenic disorder: a cross-national analysis in four countries"],"prefix":"10.1007","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9622-169X","authenticated-orcid":false,"given":"Janet","family":"Sultana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Hurtado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Bejarano-Quisoboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Giorgianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista F.","family":"Huybrechts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Patorno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Sanf\u00e9lix-Gimeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele Ugo","family":"Tari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Trifir\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,1]]},"reference":[{"key":"2654_CR1","doi-asserted-by":"crossref","unstructured":"Abrams DJ, Rojas DC, Arciniegas DB (2008) Is schizoaffective disorder a distinct categorical diagnosis? A critical review of the literature. Neuropsychiatr Dis Treat 2008;4(6):1089\u20131109","DOI":"10.2147\/NDT.S4120"},{"issue":"2","key":"2654_CR2","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1017\/S2045796012000406","volume":"22","author":"C Gayer-Anderson","year":"2013","unstructured":"Gayer-Anderson C, Morgan C (2013) Social networks, support and early psychosis: a systematic review. Epidemiol Psychiatr Sci 22(2):131\u2013146","journal-title":"Epidemiol Psychiatr Sci"},{"issue":"3","key":"2654_CR3","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1176\/appi.ajp.161.3.473","volume":"161","author":"DG Robinson","year":"2004","unstructured":"Robinson DG, Woerner MG, McMeniman M, Mendelowitz A, Bilder RM (2004) Symptomatic and functional recovery from a first episode of schizophrenia or schizoaffective disorder. Am J Psychiatry 161(3):473\u2013479","journal-title":"Am J Psychiatry"},{"issue":"5","key":"2654_CR4","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1176\/ps.50.5.667","volume":"50","author":"M Olfson","year":"1999","unstructured":"Olfson M, Mechanic D, Hansell S, Boyer CA, Walkup J (1999) Prediction of homelessness within three months of discharge among inpatients with schizophrenia. Psychiatr Serv 50(5):667\u2013673","journal-title":"Psychiatr Serv"},{"issue":"2","key":"2654_CR5","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1176\/ps.2009.60.2.210","volume":"60","author":"M Olfson","year":"2009","unstructured":"Olfson M, Marcus SC, Wan GJ (2009) Treatment patterns for schizoaffective disorder and schizophrenia among Medicaid patients. Psychiatr Serv 60(2):210\u2013216","journal-title":"Psychiatr Serv"},{"issue":"2","key":"2654_CR6","doi-asserted-by":"publisher","first-page":"78","DOI":"10.9758\/cpn.2012.10.2.78","volume":"10","author":"R Schennach","year":"2012","unstructured":"Schennach R, Riedel M, Musil R, M\u00f6ller HJ (2012) Treatment response in first-episode schizophrenia. Clin Psychopharmacol Neurosci 10(2):78\u201387","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"2654_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2147\/PROM.S42735","volume":"5","author":"PM Haddad","year":"2014","unstructured":"Haddad PM, Brain C, Jan Scott J (2014) Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies. Patient Relat Outcome Meas 5:43\u201362","journal-title":"Patient Relat Outcome Meas"},{"key":"2654_CR8","first-page":"173","volume":"4","author":"AN Ara\u00fajo De","year":"2012","unstructured":"De Ara\u00fajo AN, de Sena EP, de Oliveira IR et al (2012) Antipsychotic agents: efficacy and safety in schizophrenia. Drug Healthc Patient Saf 4:173\u2013180","journal-title":"Drug Healthc Patient Saf"},{"issue":"8","key":"2654_CR9","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1517\/14740338.2014.935761","volume":"13","author":"FM Werner","year":"2014","unstructured":"Werner FM, Cove\u00f1as R (2014) Safety of antipsychotic drugs: focus on therapeutic and adverse effects. Expert Opin Drug Saf 13(8):1031\u20131042","journal-title":"Expert Opin Drug Saf"},{"key":"2654_CR10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fphar.2017.00063","volume":"8","author":"CL Rodr\u00edguez-Bernal","year":"2017","unstructured":"Rodr\u00edguez-Bernal CL, Hurtado I, Garc\u00eda-Sempere A et al (2017) Oral anticoagulants initiation in patients with atrial fibrillation: real-world data from a population-based cohort. Front Pharmacol 8:63","journal-title":"Front Pharmacol"},{"issue":"1","key":"2654_CR11","doi-asserted-by":"publisher","first-page":"11784","DOI":"10.1038\/s41598-017-10899-6","volume":"7","author":"A Garc\u00eda-Sempere","year":"2017","unstructured":"Garc\u00eda-Sempere A, Hurtado I, Sanf\u00e9lix-Genov\u00e9s J et al (2017) Primary and secondary non-adherence to osteoporotic medications after hip fracture in Spain. The PREV2FO population-based retrospective cohort study. Sci Rep 7(1):11784","journal-title":"Sci Rep"},{"issue":"11","key":"2654_CR12","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s40263-016-0366-z","volume":"30","author":"J Sultana","year":"2016","unstructured":"Sultana J, Fontana A, Giorgianni F, Pasqua A, Cricelli C, Spina E, Gambassi G, Ivanovic J, Ferrajolo C, Molokhia M, Ballard C, Sharp S, Sturkenboom M, Trifir\u00f2 G (2016) The effect of safety warnings on antipsychotic drug prescribing in elderly persons with dementia in the United Kingdom and Italy: a population-based study. CNS Drugs 30(11):1097\u20131109","journal-title":"CNS Drugs"},{"issue":"5","key":"2654_CR13","doi-asserted-by":"publisher","first-page":"e0155805","DOI":"10.1371\/journal.pone.0155805","volume":"11","author":"Y Ingrasciotta","year":"2016","unstructured":"Ingrasciotta Y, Giorgianni F, Marcian\u00f2 I et al (2016) Comparative effectiveness of biosimilar, reference product and other erythropoiesis-stimulating agents (ESAs) still covered by patent in chronic kidney disease and Cancer patients: an Italian population-based study. PLoS One 11(5):e0155805","journal-title":"PLoS One"},{"key":"2654_CR14","doi-asserted-by":"publisher","first-page":"j2941","DOI":"10.1136\/bmj.j2941","volume":"358","author":"E Patorno","year":"2017","unstructured":"Patorno E, Glynn RJ, Levin R et al (2017) Benzodiazepines and risk of all cause mortality in adults: cohort study. BMJ 358:j2941","journal-title":"BMJ"},{"issue":"23","key":"2654_CR15","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1056\/NEJMoa1612222","volume":"376","author":"E Patorno","year":"2017","unstructured":"Patorno E, Huybrechts KF, Bateman BT, Cohen JM, Desai RJ, Mogun H, Cohen LS, Hernandez-Diaz S (2017) Lithium use in pregnancy and the risk of cardiac malformations. N Engl J Med 376(23):2245\u20132254","journal-title":"N Engl J Med"},{"issue":"10","key":"2654_CR16","doi-asserted-by":"publisher","first-page":"e0139403","DOI":"10.1371\/journal.pone.0139403","volume":"10","author":"AM Gaviria","year":"2015","unstructured":"Gaviria AM, Franco JG, Aguado V, Rico G, Labad J, de Pablo J, Vilella E (2015) A non-interventional naturalistic study of the prescription patterns of antipsychotics in patients with schizophrenia from the Spanish Province of Tarragona. PLoS One 10(10):e0139403","journal-title":"PLoS One"},{"issue":"4","key":"2654_CR17","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.euroneuro.2014.01.014","volume":"24","author":"MX Patel","year":"2014","unstructured":"Patel MX, Bishara D, Jayakumar S, Zalewska K, Shiers D, Crawford MJ, Cooper SJ (2014) Quality of prescribing for schizophrenia: evidence from a national audit in England and Wales. Eur Neuropsychopharmacol 24(4):499\u2013509","journal-title":"Eur Neuropsychopharmacol"},{"issue":"4","key":"2654_CR18","first-page":"242","volume":"27","author":"W Lawson","year":"2015","unstructured":"Lawson W, Johnston S, Karson C, Offord S, Docherty J, Eramo A, Kamat S, Blanchette CM, Carson W, Nasrallah HA (2015) Racial differences in antipsychotic use: claims database analysis of Medicaid-insured patients with schizophrenia. Ann Clin Psychiatry 27(4):242\u2013252","journal-title":"Ann Clin Psychiatry"},{"issue":"1","key":"2654_CR19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00228-004-0868-3","volume":"61","author":"G Trifir\u00f2","year":"2005","unstructured":"Trifir\u00f2 G, Spina E, Brignoli O et al (2005) Antipsychotic prescribing pattern among Italian general practitioners: a population-based study during the years 1999-2002. Eur J Clin Pharmacol 61(1):47\u201353","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"2654_CR20","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s40801-015-0043-4","volume":"2","author":"JA Pesa","year":"2015","unstructured":"Pesa JA, Muser E, Montejano LB, Smith DM, Meyers OI (2015) Costs and resource utilization among Medicaid patients with schizophrenia treated with paliperidone palmitate or oral atypical antipsychotics. Drugs Real World Outcomes 2(4):377\u2013385","journal-title":"Drugs Real World Outcomes"},{"key":"2654_CR21","doi-asserted-by":"publisher","first-page":"619","DOI":"10.2147\/PPA.S127623","volume":"11","author":"D Pilon","year":"2017","unstructured":"Pilon D, Joshi K, Tandon N et al (2017) Treatment patterns in Medicaid patients with schizophrenia initiated on a first- or second-generation long-acting injectable versus oral antipsychotic. Patient Prefer Adherence 11:619\u2013629","journal-title":"Patient Prefer Adherence"},{"key":"2654_CR22","doi-asserted-by":"crossref","unstructured":"Gaviria AM, Franco J, Rico G, Muntan\u00e9 G, S\u00e1ez C, S\u00e1nchez-Gistau V, de Pablo J, Vilella E (2017) Noninterventional, naturalistic, retrospective study to describe prescription patterns of long-acting injectable antipsychotics and the impact of introducing a new atypical antipsychotic in the Spanish Province of Tarragona catchment area. Prim Care Companion CNS Disord 19(2)","DOI":"10.4088\/PCC.16m02044"},{"issue":"2","key":"2654_CR23","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1080\/13696998.2017.1379412","volume":"21","author":"M Greene","year":"2018","unstructured":"Greene M, Yan T, Chang E, Hartry A, Touya M, Broder MS (2018) Medication adherence and discontinuation of long-acting injectable versus oral antipsychotics in patients with schizophrenia or bipolar disorder. J Med Econ 21(2):127\u2013134","journal-title":"J Med Econ"},{"issue":"11","key":"2654_CR24","first-page":"1349","volume":"22","author":"JP MacEwan","year":"2016","unstructured":"MacEwan JP, Forma FM, Shafrin J, Hatch A, Lakdawalla DN, Lindenmayer JP (2016) Patterns of adherence to oral atypical antipsychotics among patients diagnosed with schizophrenia. J Manag Care Spec Pharm 22(11):1349\u20131361","journal-title":"J Manag Care Spec Pharm"},{"issue":"5","key":"2654_CR25","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.eurpsy.2008.12.002","volume":"24","author":"JM Olivares","year":"2009","unstructured":"Olivares JM, Rodriguez-Morales A, Diels J, Povey M, Jacobs A, Zhao Z, Lam A, Villalobos Vega JC, Cu\u00e9llar JA, de Castro FJ, Quintero CM, Mart\u00edin JF, Dom\u00ednguez P, Ojeda JL, Cort\u00e9s SS, Cala FI, Mar\u00edn CG, Castro LM, Duaso MA, Albarrac\u00edn JR, Vergara GN, Ben\u00edtez AF, Cleries FM, P\u00e9rez-Brian JM, Arag\u00f3n AB, Navarro JC, Biedma JA, de Pedro RB, Gonz\u00e1lez JF, L\u00f3pez ME, Moreno HD, L\u00f3pez JA, Rodr\u00edguez EO, de Hoyos CM, Sacrist\u00e1n MP, Mart\u00edn MD, Ballesteros EM, Rodr\u00edguez PA, Men\u00e9ndez LF, Rivas RS, del Pino Cuadrado P, Lauffer JC, Solano JJ, Mart\u00ednez JM, Solano FG, Rodr\u00edguez PG, Rodr\u00edguez JA, Cano TR, Fortacin MD, Lobeiras JM, Sampedro JM, Bravo AP, Pellicer AF, L\u00f3pez MD, Liste JF, Fern\u00e1ndez MR, Losada AC, Mendez RV, Romero SA, Blanco JJ, Bonaselt IT, Mahia MC, del Valle E, Ya\u00f1ez PQ, Camarasa MG, Alonso JA, Mendez GF, Feliz FD, Lamela MA, Pi\u00f1ero MV, Alvarado PF, G\u00f3mez IL, Mart\u00edn PF, G\u00f3mez JL, L\u00f3pez AG, Jim\u00e9nez AR, Nafs AE, Barquero NC, Ortiz RF, Noguera JL, Carrasco PR, Mu\u00f1oz JM, Palma MM, Hortelano CM, Bonome LS, Sevilla JS, Juan JM, Ramos JM, Mu\u00f1oz JL, Guisasola JE, Vazquez LS, Guerras FC, Nebot FJ, Fern\u00e1ndez FJ, Nicolau AL, Subirats RC, Kidias MM, Navarro VF, Garc\u00eda BF, del Rosal F, de Vicente Mu\u00f1oz T, Ballester JA, Lieb PM, Martel AD, Bea ER, Joaquim IG, Enjuanes FB, Pi\u00f1ol MB, Carbonell EF, Mu\u00f1oz RM, Giribets CA, Sans LA, Blanco AS, Felipe MA, Mu\u00f1oz PG, Villanueva AP, Arroyo MB, Borri RC, Fallada SM, Merola MC, Rodon EP, Palmes JR, Mart\u00ednez EP, Catala JM, Coca AS, Ferrandiz FP, Paya EF, Caballero GI, Bonet AF, Figueras JF, Pagador PM, Garibo MM, Camo VP, Carrillo CS, Valero CP, Rebollo FJ, Garc\u00eda Campayo J, Sala Ayma JM, Roig MM, de U\u00f1a Mateos MA, Bertolin RG, Garc\u00eda AM, Mazo FJ, Velasco JL, P\u00e9rez LS, Casado CJ, Barba JJ, Diaz MC, Rubio JP, Mandoli AS, Herrero AU, Mart\u00ednez AR, Serrano PS, Rodr\u00edguez EN, Montesinos JS, Macia JF, Mateos Marcos AM, Soto JV, Dumont MV, Pagan JP, Mart\u00ednez VB, Santiuste de Pablos M, Delgado CE, Quiles MD, L\u00f3pez FJ, Navarro PP, Torres AM, Ingles FJ, Arias-Camison JM, Manzano JC, Pe\u00f1a RV, Guitarte GP, Fontecilla HB, Romero JB, Gil RS, Lozano JM, Adanez LD, Zarranz Herrera-Oria I, Jim\u00e9nez JP, Vaz FC, Garc\u00eda OS, Anton CC, Casula RR, Hernandez MC, Escabias FT, Torresano JR, P\u00e9rez-Villamil AH, Estevez L, Figuero MA, Mu\u00f1oz de Morales A, Calvin JL, Criado MD, Rodr\u00edguez VM, Ambrosolio EB, Madera PM, Alfaro GP, Vidal MM, Valtuille AG, Ruiz O, Cabornero GL, Echevarria Mart\u00ednez de Bujo M, Mallen MJ, Puigros JS, Martorell AL, Forteza AC, Arrebola ER, Rodr\u00edguez de la Torre M, Saiz CG, Bardolet I Casas C, Linde ER, de Arce Cordon R, Molina EM, Carazo FJ, Romero JJ, Cano DV, Dorado MS, Velazquez SC, S\u00e1nchez AJ, Leon SO, S\u00e1nchez KP, Benitez MH, Zugarramurai AI, Contreras MA, de la Varga Gonz\u00e1lez M, Mar\u00edn PB, Robina FG, Garc\u00eda MS, P\u00e9rez FJ, Bros PC, G\u00f3mez AC, de Dios Molina Mart\u00edn J, Perera JL, Averbach MC, Perera JL, Palancares EG, Gallego de Dios MT, Rojo CF, Iglesias SS, Merino MI, Mestre NP, Urdaniz AP, S\u00e1nchez JM, Seco RG, Mu\u00f1oz JF, Agut MM, Lozano ML, Herguedas FM, Pena AT, Garc\u00eda JV, Mart\u00ednez AV, Sanz Granado OS, Fern\u00e1ndez MA, Canseco JM, L\u00f3pez PA, Mart\u00edn MA, Barrio JA, Ubago JG, Bennassar MR, D\u00edez JM, Fleta JL, Fortes FP, L\u00f3pez CA, Medina O, Alvarez DF, Roca JM, Valladolid GR, Tavera JA, Garc\u00eda-Castrillon Sales JA, Llordes IB, Melgarejo CA, Ca\u00f1as de la Paz F, Callol VV, Garc\u00eda MB, Garc\u00eda JB, Leal FJ, Corrales EC, Iglesias ES, G\u00f3mez MA, Serrano GG, Chillar\u00f3n EG, Aguado FJ, Castillo JJ, Gonz\u00e1lez AG, V\u00e1zquez JG, Peralvarez MB, Diaz MR, Mesa MY, Artiles FJ, Chao MA, Mesa MY, del Rosario Santana P, Escudero MA, Berenguer MM, Llacer JM, Berna JA, Ortiz JB, Pardell LT, Hern\u00e1ndez-Alvarez de Sotomayor C, M\u00e9ndez MR, Garate RC, M\u00fagica BD, Gonz\u00e1lez MC, Domingo JP, Navarro CS, Vera GS, Cuquerella MA, Monzo JL, Boada PC, P\u00e9rez MF, Parrado EC, S\u00e1nchez JJ, Fern\u00e1ndez JC, e-STAR Spanish Study Group (2009) Long-term outcomes in patients with schizophrenia treated with risperidone long-acting injection or oral antipsychotics in Spain: results from the electronic Schizophrenia Treatment Adherence Registry (e-STAR). Eur Psychiatry 24(5):287\u2013296","journal-title":"Eur Psychiatry"},{"key":"2654_CR26","unstructured":"National Institute for Health and Care Excellence (NICE). Clinical guideline [CG178]: psychosis and schizophrenia in adults: prevention and management. Published date: February 2014. Last updated: March 2014. Available from: \n                    https:\/\/www.nice.org.uk\/guidance\/CG178\/chapter\/1-Recommendations#choice-of-antipsychotic-medication\n                    \n                  . Accessed on 12\/06\/2017"},{"issue":"4","key":"2654_CR27","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1177\/2045125312474019","volume":"3","author":"K Higashi","year":"2013","unstructured":"Higashi K, Medic G, Littlewood KJ, Diez T, Granstr\u00f6m O, de Hert M (2013) Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review. Ther Adv Psychopharmacol 3(4):200\u2013218","journal-title":"Ther Adv Psychopharmacol"},{"issue":"9","key":"2654_CR28","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/phar.1634","volume":"35","author":"Y Jiang","year":"2015","unstructured":"Jiang Y, Ni W (2015) Estimating the impact of adherence to and persistence with atypical antipsychotic therapy on health care costs and risk of hospitalization. Pharmacotherapy 35(9):813\u2013822","journal-title":"Pharmacotherapy"},{"key":"2654_CR29","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.2147\/PPA.S87551","volume":"9","author":"E Costa","year":"2015","unstructured":"Costa E, Giardini A, Savin M, Menditto E, Lehane E, Laosa O, Pecorelli S, Monaco A, Marengoni A (2015) Interventional tools to improve medication adherence: review of literature. Patient Prefer Adherence 9:1303\u20131314","journal-title":"Patient Prefer Adherence"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02654-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-019-02654-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02654-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T19:05:43Z","timestamp":1582916743000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-019-02654-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,1]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["2654"],"URL":"https:\/\/doi.org\/10.1007\/s00228-019-02654-9","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,1]]},"assertion":[{"value":"15 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure of potential conflicts of interest"}}]}}